Achilles therapeutics presents positive data at esmo i-o congress 2021 on high-dose manufacturing process for precision t cell therapies targeting clonal neoantigens

-over 10-fold dose increase at gmp scale with velos™ process 2 manufacturing-

ACHL Ratings Summary

ACHL Quant Ranking